QuilliChew ER Approval History
- FDA approved: Yes (First approved December 7th, 2015)
- Brand name: QuilliChew ER
- Generic name: methylphenidate hydrochloride
- Dosage form: Extended Release Chewable Tablets
- Company: Pfizer Inc.
- Treatment for: ADHD
QuilliChew ER (methylphenidate hydrochloride) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Development History and FDA Approval Process for QuilliChew ER
|Dec 7, 2015||Pfizer Receives FDA Approval for QuilliChew ER (methylphenidate hydrochloride) Extended-Release Chewable Tablets|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.